Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Recent progress in radionuclide therapy].

K Kasagi1, M Iwata, T Misaki

  • 1Department of Nuclearmedicine and Diagnostic Imaging, Graduate of Medicine, Kyoto University.

Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica
|January 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shear Stiffness of 4 Common Intracranial Tumors Measured Using MR Elastography: Comparison with Intraoperative Consistency Grading.

AJNR. American journal of neuroradiology·2016
Same author

Hemodynamic assessment of celiaco-mesenteric anastomosis in patients with pancreaticoduodenal artery aneurysm concomitant with celiac artery occlusion using flow-sensitive four-dimensional magnetic resonance imaging.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2013
Same author

Accurate determination of patient-specific boundary conditions in computational vascular hemodynamics using 3D cine phase-contrast MRI.

International journal for numerical methods in biomedical engineering·2013
Same author

Arterial spin-labeled perfusion imaging reflects vascular density in nonfunctioning pituitary macroadenomas.

AJNR. American journal of neuroradiology·2013
Same author

Time-resolved optical mammography and its preliminary clinical results.

Technology in cancer research & treatment·2011
Same author

Serum cytokeratin-19 measured by cyfra21-1 assay in patients with gastrointestinal and gynecologic malignancy.

International journal of oncology·2011
Same journal

[Abstracts of the 45th Autumn Meeting of the Japanese Radiological Society. October 29-31, 2009. Wakayama, Japan].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·2010
Same journal

[Abstracts of the 68th Annual Meeting of the Japanese Radiological Society. April 16-19, 2009. Yokohama, Japan].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·2010
Same journal

[The 44th Autumn Meeting of the Japanese Radiological Society. Fukushima, Japan. October 22-24, 2008. Abstracts].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·2009
Same journal

[The 67th Annual Meeting of the Japanese Radiological Society. Yokohama, Japan. April 4-6, 2008. Abstracts].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·2009
Same journal

[The 43rd autumn meeting of the Japan Radiological Society. Nagoya, Japan. October 25-27, 2007. Abstracts].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·2007
Same journal

[The 66th annual meeting of the Japan Radiological Society. Yokohama, Japan. April 13-15, 2007. Abstracts].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·2007
See all related articles

Radionuclide therapy, including iodine-131 (131I) for thyroid cancer, offers significant benefits for patients with metastatic bone tumors and certain cancers. Early detection of metastases in younger patients improves survival rates and treatment outcomes.

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Endocrinology

Context:

  • Radionuclide therapy is a key treatment modality for various cancers, including thyroid cancer, bone metastases, pheochromocytoma, neuroblastoma, and lymphoma.
  • Iodine-131 (131I) demonstrates significant uptake in differentiated thyroid cancer metastases, particularly in younger patients.
  • Tumor-produced thyroid hormones can partially or fully compensate for hypothyroidism post-thyroidectomy.

Purpose:

  • To review the therapeutic applications of radionuclides in cancer treatment.
  • To highlight the efficacy of iodine-131 (131I) in managing differentiated thyroid cancer.
  • To emphasize the importance of early metastasis detection and long-term follow-up.

Summary:

  • Iodine-131 (131I) effectively reduces thyroid cancer metastasis size and number, correlating with lower recurrence and higher survival rates.

Related Experiment Videos

  • Strontium-89 chloride (89SrCl3) alleviates pain from bone metastases, while iodine-131-meta-iodobenzylguanidine (131I-MIBG) improves quality of life in pheochromocytoma.
  • Radioimmunotherapy targeting CD20 shows success in treating malignant B-cell lymphoma.

    • Impact:

    • Early identification of metastases, especially in younger individuals, is crucial for improved long-term survival.
    • Favorable prognostic factors include younger age, well-differentiated histology, limited disease extent, and prompt metastasis discovery.
    • Long-term patient management requires periodic thyroglobulin monitoring and imaging studies.